Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization

Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry

(2014) Matthijs A. Velders et al.   AMERICAN HEART JOURNAL

Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction

(2014) Andriy Yabluchanskiy et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Aliskiren and valsartan mediate left ventricular remodeling post-myocardial infarction in mice through MMP-9 effects

(2014) Trevi A. Ramirez et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction

(2014) Lei Gao et al.   Clinical Interventions in Aging

Heart Disease and Stroke Statistics—2014 Update

(2013) Alan S. Go et al.   CIRCULATION

Enhanced Efferocytosis of Apoptotic Cardiomyocytes Through Myeloid-Epithelial-Reproductive Tyrosine Kinase Links Acute Inflammation Resolution to Cardiac Repair After Infarction

(2013) Elaine Wan et al.   CIRCULATION RESEARCH

Monocyte and Macrophage Heterogeneity in the Heart

(2013) Matthias Nahrendorf et al.   CIRCULATION RESEARCH

Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease

(2013) Andriy Yabluchanskiy et al.   PHYSIOLOGY

Senescent Cardiac Fibroblast Is Critical for Cardiac Fibrosis after Myocardial Infarction

(2013) Fuli Zhu et al.   PLoS One

Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice

(2012) Ying Ann Chiao et al.   CARDIOVASCULAR RESEARCH

Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial

(2011) Damian J. Kelly et al.   AMERICAN HEART JOURNAL

Heart Disease and Stroke Statistics—2012 Update

(2011) et al.   CIRCULATION

Biochemical Analysis of Matrix Metalloproteinase Activation of Chemokines CCL15 and CCL23 and Increased Glycosaminoglycan Binding of CCL16

(2011) Amanda E. Starr et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: Findings from the CRUSADE initiative

(2010) Shahyar Michael Gharacholou et al.   AMERICAN HEART JOURNAL

Cardiac Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase Causes Adverse Myocardial Remodeling following Myocardial Infarction

(2010) Francis G. Spinale et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Chemokines, neuronal–glial interactions, and central processing of neuropathic pain

(2010) Yong-Jing Gao et al.   PHARMACOLOGY & THERAPEUTICS

Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries

(2009) P. Widimsky et al.   EUROPEAN HEART JOURNAL

Osteopontin: Role in extracellular matrix deposition and myocardial remodeling post-MI

(2009) Mahipal Singh et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction

(2009) Marcin Dobaczewski et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke

(2008) Robert C. Kaplan et al.   ATHEROSCLEROSIS

Accumulation of fibronectin in the heart after myocardial infarction: a putative stimulator of adhesion and proliferation of adipose-derived stem cells

(2008) A. van Dijk et al.   CELL AND TISSUE RESEARCH

Aging-Related Defects Are Associated With Adverse Cardiac Remodeling in a Mouse Model of Reperfused Myocardial Infarction

(2008) Marcin Bujak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY